Thomas M. Fasy

956 total citations
33 papers, 781 citations indexed

About

Thomas M. Fasy is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Thomas M. Fasy has authored 33 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Thomas M. Fasy's work include Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Thomas M. Fasy is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Thomas M. Fasy collaborates with scholars based in United States, South Africa and Canada. Thomas M. Fasy's co-authors include Marc Monestier, Kristine E. Novick, Michele J. Losman, Edward M. Johnson, J. Kallos, Vincent P. Hollander, Sylviane Muller, D. Stave Kohtz, L. Böhm and Michael D. Bick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Thomas M. Fasy

33 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas M. Fasy United States 17 334 241 190 141 101 33 781
L. Mengle-Gaw United Kingdom 16 521 1.6× 401 1.7× 169 0.9× 158 1.1× 20 0.2× 20 1.1k
Arnaud Dupuy d’Angeac France 11 410 1.2× 251 1.0× 105 0.6× 245 1.7× 24 0.2× 28 886
Haruhiko Imai Japan 14 223 0.7× 387 1.6× 252 1.3× 114 0.8× 28 0.3× 28 919
C Cordón-Cardó United States 13 274 0.8× 419 1.7× 70 0.4× 41 0.3× 61 0.6× 19 891
Paul Hobby United Kingdom 16 954 2.9× 218 0.9× 168 0.9× 83 0.6× 41 0.4× 24 1.3k
Yataro Yoshida Japan 18 204 0.6× 404 1.7× 42 0.2× 56 0.4× 74 0.7× 85 1.1k
Arnold D. Rubin United States 17 245 0.7× 289 1.2× 157 0.8× 26 0.2× 41 0.4× 33 848
C A Penning United States 13 226 0.7× 436 1.8× 69 0.4× 116 0.8× 59 0.6× 17 918
Karen Berry United States 9 471 1.4× 144 0.6× 85 0.4× 127 0.9× 17 0.2× 12 755
Robert N. McEwan United States 15 184 0.6× 436 1.8× 64 0.3× 34 0.2× 58 0.6× 20 811

Countries citing papers authored by Thomas M. Fasy

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Fasy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Fasy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Fasy more than expected).

Fields of papers citing papers by Thomas M. Fasy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Fasy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Fasy. The network helps show where Thomas M. Fasy may publish in the future.

Co-authorship network of co-authors of Thomas M. Fasy

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Fasy. A scholar is included among the top collaborators of Thomas M. Fasy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Fasy. Thomas M. Fasy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Alexander S., Lu-Hai Wang, Yun Peng Huang, et al.. (2001). Pilot Study of a Specific Dietary Supplement inTumor-Bearing Mice and in Stage IIIB and IV Non-Small Cell Lung Cancer Patients. Nutrition and Cancer. 39(1). 85–95. 19 indexed citations
2.
Sun, Alexander S., et al.. (1999). Phase I/II Study of Stage III and IV Non-Small Cell Lung Cancer Patients Taking a Specific Dietary Supplement. Nutrition and Cancer. 34(1). 62–69. 21 indexed citations
4.
Monestier, Marc, Thomas M. Fasy, Kristine E. Novick, et al.. (1994). Histone-Reactive IgA Antibodies in Adult IgA Nephropathy and Other Primary Glomerulonephritis. ˜The œNephron journals/Nephron journals. 68(1). 25–31. 3 indexed citations
5.
Losman, Michele J., Thomas M. Fasy, Kristine E. Novick, & Marc Monestier. (1993). Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA. International Immunology. 5(5). 513–523. 55 indexed citations
6.
Gan, Lin, et al.. (1993). Transfection of Human Mesothelial Cells Mediated by Different Asbestos Fiber Types. Environmental Research. 62(1). 28–42. 9 indexed citations
7.
Losman, Julie A., et al.. (1993). Nucleosome‐specific antibody from an autoimmune mrl/mp‐lpr/lpr mouse. Arthritis & Rheumatism. 36(4). 552–560. 33 indexed citations
8.
Monestier, Marc, Thomas M. Fasy, Michele J. Losman, Kristine E. Novick, & Sylviane Muller. (1993). Structure and binding properties of monoclonal antibodies to core histones from autoimmune mice. Molecular Immunology. 30(12). 1069–1075. 79 indexed citations
9.
Losman, Michele J., Thomas M. Fasy, Kristine E. Novick, & Marc Monestier. (1992). Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. The Journal of Immunology. 148(5). 1561–1569. 156 indexed citations
10.
Novick, Kristine E., Thomas M. Fasy, Michele J. Losman, & Marc Monestier. (1992). Polyreactive IgM antibodies generated from autoimmune mice and selected for histone-binding activity. International Immunology. 4(10). 1103–1111. 27 indexed citations
11.
Heimann, Tomas M., Giorgio P. Martinelli, Arnold H. Szporn, et al.. (1992). Colorectal carcinoma associated with ulcerative colitis: A study of prognostic indicators. The American Journal of Surgery. 164(1). 13–17. 24 indexed citations
12.
Heimann, Tomas M., et al.. (1991). DNA ploidy of colorectal cancer and synchronous polyps in polyposis coli. Diseases of the Colon & Rectum. 34(12). 1103–1108. 2 indexed citations
13.
Monestier, Marc, Thomas M. Fasy, L. Böhm, & Frank S. Lieberman. (1991). Anti-histone antibodies in subacute sensory neuropathy. Journal of Neuro-Oncology. 11(1). 71–75. 5 indexed citations
14.
Monestier, Marc, Julie A. Losman, Thomas M. Fasy, et al.. (1990). Antihistone antibodies in antinuclear antibody—positive juvenile Arthritis. Arthritis & Rheumatism. 33(12). 1836–1841. 30 indexed citations
15.
Hellman, Judith, et al.. (1990). Lymphomatoid Papulosis with Antigen Deletion and Clonal Rearrangement in a 4‐Year‐Old Boy. Pediatric Dermatology. 7(1). 42–47. 24 indexed citations
16.
Heimann, Tomas M., et al.. (1990). Significance of DNA content abnormalities in small rectal cancers. The American Journal of Surgery. 159(2). 199–202. 21 indexed citations
17.
Monestier, Marc, Thomas M. Fasy, & L. Böhm. (1989). Monoclonal anti-histone H1 autoantibodies from MRL lpr/lpr mice☆. Molecular Immunology. 26(8). 749–758. 26 indexed citations
18.
Thung, Swan N., et al.. (1989). Hepatitis B surface antigen binds to human serum albumin cross-linked by transglutaminase†. Hepatology. 9(5). 726–730. 11 indexed citations
19.
Fasy, Thomas M., et al.. (1988). Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA.. Proceedings of the National Academy of Sciences. 85(20). 7670–7674. 59 indexed citations
20.
Reed, E, et al.. (1986). Biomonitoring of cisplatin-DNA adducts in cancer patients receiving cisplatin chemotherapy.. PubMed. 209B. 247–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026